Related references
Note: Only part of the references are listed.Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
Ivana Sullivan et al.
CANCER LETTERS (2014)
Associations of Polymorphisms in DNA Repair Genes and MDR1 Gene with Chemotherapy Response and Survival of Non-Small Cell Lung Cancer
Yan Du et al.
PLOS ONE (2014)
Potentially functional polymorphisms in the ERCC2 gene and risk of Esophageal Squamous Cell Carcinoma in Chinese populations
Mei-Ling Zhu et al.
SCIENTIFIC REPORTS (2014)
XPG is Predictive Gene of Clinical Outcome in Advanced Non-small-cell Lung Cancer with Platinum Drug Therapy
Tian Zhang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Association between polymorphisms in ERCC2 gene and oral cancer risk: evidence from a meta-analysis
Enjiao Zhang et al.
BMC CANCER (2013)
Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy
Shin Yup Lee et al.
LUNG CANCER (2013)
Genetic Variation in BCL2 3 '-UTR Was Associated with Lung Cancer Risk and Prognosis in Male Chinese Population
Ping Xu et al.
PLOS ONE (2013)
Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis
Zhigang Cui et al.
BMC CANCER (2012)
Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy
Dorota Butkiewicz et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis
Zhen Feng et al.
MOLECULAR BIOLOGY REPORTS (2012)
Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy
Shengxiang Ren et al.
LUNG CANCER (2012)
Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy
Seok-Hyun Kim et al.
LUNG CANCER (2012)
The Effect of XPD/ERCC2 Polymorphisms on Gastric Cancer Risk among Different Ethnicities: A Systematic Review and Meta-Analysis
Huiping Xue et al.
PLOS ONE (2012)
Pharmacogenetic role of ERCC1 genetic variants in treatment response of platinum-based chemotherapy among advanced non-small cell lung cancer patients
Dianke Yu et al.
TUMOR BIOLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
DNA Repair Gene Polymorphisms and Benefit From Gefitinib in Never-Smokers With Lung Adenocarcinoma
Ji-Youn Han et al.
CANCER (2011)
Single Nucleotide Polymorphisms in Tobacco Metabolism and DNA Repair Genes and Prognosis in Resected Non-Small-Cell Lung Cancer
Marc Campayo et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Differential Effect of Polymorphisms of CMPK1 and RRM1 on Survival in Advanced Non-small Cell Lung Cancer Patients Treated with Gemcitabine or Taxane/Cisplatinum
Jeong-Seon Ryu et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer
Dorota Butkiewicz et al.
MOLECULAR BIOLOGY REPORTS (2011)
Role of DNA Repair Gene Polymorphisms in the Efficiency of Platinum-Based Adjuvant Chemotherapy for Non-Small Cell Lung Cancer
Juliette Mathiaux et al.
MOLECULAR DIAGNOSIS & THERAPY (2011)
No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: A meta-analysis
Ming Yin et al.
LUNG CANCER (2011)
Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk
Biyun Qian et al.
LUNG CANCER (2011)
Nonsynonymous Single Nucleotide Polymorphisms in DNA Damage Repair Pathways and Lung Cancer Risk
Yugo Tanaka et al.
CANCER (2010)
Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer
Min Kim et al.
CANCER SCIENCE (2010)
Association of DNA Repair Gene Polymorphisms With Response to Platinum-Based Doublet Chemotherapy in Patients With Non-Small-Cell Lung Cancer
Kouya Shiraishi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma
Zhihua Yin et al.
BMC CANCER (2009)
Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients
Xinchen Sun et al.
LUNG CANCER (2009)
Emerging ethnic differences in lung cancer therapy
I. Sekine et al.
BRITISH JOURNAL OF CANCER (2008)
Molecular origins of cancer: Lung cancer
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: A meta-analysis
Chikako Kiyohara et al.
LUNG CANCER (2006)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A. Olaussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Polymorphisms of DNA repair genes and risk of non-small cell lung cancer
S Zienolddiny et al.
CARCINOGENESIS (2006)
DNA repair and cisplatin resistance in non-small-cell lung cancer
R Rosell et al.
LUNG CANCER (2002)
XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions
AE Vidal et al.
EMBO JOURNAL (2001)
Share Paper
